Intelligent Bio Solutions INC 8-K filings

Intelligent Bio Solutions Inc. announced a 114% year-over-year revenue increase for the second fiscal quarter and a 337% increase for the six months ended December 31, 2023.

Intelligent Bio Solutions' fingerprint drug screening system will be deployed across 25 UK sites of James Jones & Sons, a leading timber processor, to support their new substance misuse policy.

Intelligent Bio Solutions implemented a 1-for-12 reverse stock split to increase its share price and comply with Nasdaq's minimum listing requirements.